Sclerotinia sclerotiorum SsCAK1 protein and its encoding gene and application

By inhibiting the expression of SsCAK1 gene of SsCAK1, using interfering sequence and recombinant vector technology, the resistance of plants to SsCAK1 is improved, and the problem of inability to effectively control SsCAK1 in the prior art has been solved, and the lesion area has been significantly reduced and enhance disease resistance.

CN115894648BActive Publication Date: 2024-11-29HUNAN AGRI UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202211128458.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-09-16
Publication Date
2024-11-29
Estimated Expiration
2042-09-16

AI Technical Summary

Technical Problem

The prior art cannot effectively control sclerosis caused by sclerosis, and the chemical prevention and control costs are high and the environmental pollution is high, and there is a lack of effective disease-resistant gene resources to improve plant disease resistance.

Method used

By designing and constructing RNAi sequences that inhibit or silencing SsCAK1 gene expression, it is transformed into plants using interfering sequences and recombinant vectors to inhibit the expression of SsCAK1 protein, thereby increasing the resistance of plants to sclerosis.

Benefits of technology

It effectively reduces the susceptibility of plants to sclerosis, significantly reduces the area of ​​the disease, and enhances the antibacterial sclerosis ability of plants, with huge breeding application prospects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0003849937500000071
    Figure BDA0003849937500000071
  • Figure BDA0003849937500000081
    Figure BDA0003849937500000081
  • Figure BDA0003849937500000091
    Figure BDA0003849937500000091
Patent Text Reader

Abstract

The present invention discloses a SsCAK1 protein of Sclerotinia sclerotiorum and a coding gene and application thereof, wherein the amino acid sequence of the SsCAK1 protein of Sclerotinia sclerotiorum is shown in SEQ ID NO. 1. By designing and synthesizing an RNAi sequence for targeting and silencing the SsCAK1 gene of Sclerotinia sclerotiorum, the RNAi sequence for inhibiting or silencing the expression of the SsCAK1 gene of Sclerotinia sclerotiorum is used to construct and obtain a silencing expression vector, and after transforming the vector into a plant, the plant can be made resistant to sclerotinia sclerotiorum, and the vector has great application prospects in plant breeding for resistance to sclerotinia sclerotiorum.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of plant genetic engineering, and in particular relates to a Sclerotinia sclerotiorum SsCAK1 protein and a coding gene and application thereof. Background Art

[0002] Sclerotinia sclerotiorum (Lib.) de Bary is not only a disease of the model plant Arabidopsis thaliana, but also one of the major diseases that endanger the production of many important crops in my country.

[0003] Sclerotinia mainly survives in the form of sclerotia, which are extremely resistant to adversity and can survive in the soil for many years. During the infection process of Sclerotinia, sclerotia can directly germinate into hyphae and infect plants; or they can germinate ascospores through germination of ascospores to form hyphae, thereby infecting plants. Before invading plant tissues, hyphae first expand on the host surface to form infection pads or appressorium, penetrate healthy plant epidermis, and hyphae produce more branches. Subsequently, Sclerotinia synthesizes and secretes a variety of hydrolases and toxins such as oxalic acid to break through the host surface protection, degrade cell walls, macerate and kill host tissues, provide nutrition for the pathogen, and facilitate further invasion and proliferation of hyphae. Therefore, if the growth and formation of sclerotia or hyphae of Sclerotinia is blocked, sclerotinia disease can be effectively controlled.

[0004] At present, chemical prevention and control and agricultural prevention methods are unable to effectively control the occurrence of diseases, and are costly and cause great environmental pollution. Therefore, it is of great significance for crop breeding and agricultural production to deeply explore disease-resistant genes, especially gene resources with broad-spectrum resistance to pathogens, so as to improve plant disease resistance. Summary of the invention

[0005] The present invention aims to solve at least one of the technical problems existing in the above-mentioned prior art. To this end, the present invention aims to solve at least one of the technical problems existing in the prior art. To this end, the present invention provides a protein that can be used to improve the resistance of plants to sclerotinia disease.

[0006] The present invention also provides a biological material related to the above protein.

[0007] The present invention also provides an application of the protein and biological material.

[0008] The invention also provides a product for preventing and treating sclerotinia disease.

[0009] The invention also provides a substance for inhibiting or silencing the expression of SsCAK1 gene of Sclerotinia sclerotiorum.

[0010] The present invention also provides a primer for amplifying the above interfering sequence.

[0011] The present invention also proposes the use of the substance for inhibiting or silencing the expression of the SsCAK1 gene of Sclerotinia sclerotiorum in the preparation of products for preventing and treating sclerotinia disease.

[0012] The invention also provides a method for constructing a recombinant vector containing the interfering sequence.

[0013] The invention also provides a method for preparing the transgenic plant.

[0014] In the first aspect of the present invention, a protein is provided, which is the protein of a) or b) or c) or d) as follows:

[0015] a) a protein with an amino acid sequence as shown in SEQ ID NO.2;

[0016] b) a fusion protein obtained by connecting a tag to the N-terminus and / or C-terminus of a protein with an amino acid sequence as shown in SEQ ID NO.2;

[0017] c) a protein having the same function obtained by replacing and / or deleting and / or adding one or more amino acid residues of the amino acid sequence shown in SEQ ID NO.2;

[0018] d) A protein having more than 75% homology with the amino acid sequence shown in SEQ ID NO. 2 and having the same function.

[0019] In some embodiments of the present invention, the protein is SsCAK1 protein.

[0020] In a second aspect of the present invention, a biomaterial is provided, which is any one of the following 1) to 8):

[0021] 1) A nucleic acid molecule encoding the above-mentioned protein;

[0022] 2) an expression cassette containing the nucleic acid molecule described in 1);

[0023] 3) a recombinant vector containing the nucleic acid molecule described in 1);

[0024] 4) a recombinant vector containing the expression cassette described in 2);

[0025] 5) A recombinant microorganism containing the nucleic acid molecule described in 1);

[0026] 6) a recombinant microorganism containing the expression cassette described in 2);

[0027] 7) A recombinant microorganism containing the recombinant vector described in 3);

[0028] 8) A recombinant microorganism containing the recombinant vector described in 4).

[0029] In some embodiments of the present invention, the nucleotide sequence of the nucleic acid molecule is shown as SEQ ID NO.1.

[0030] In the third aspect of the present invention, the application of the above-mentioned protein and biomaterial is provided, wherein the application is the application in any one of (1) to (3);

[0031] (1) Anti-bacterial sclerotinia;

[0032] (2) preparing products that resist sclerotinia;

[0033] (3) Cultivate transgenic plants resistant to sclerotinia sclerotinia.

[0034] In some embodiments of the present invention, the sclerotinia disease is a plant disease caused by fungi of the genera Sclerotinia, Monilinia, Rhizoctonia and Sclerotium.

[0035] In a fourth aspect of the present invention, a product for preventing and controlling sclerotinia disease is provided, wherein the product comprises the above-mentioned biological material.

[0036] In the fifth aspect of the present invention, a substance for inhibiting or silencing the expression of SsCAK1 gene of Sclerotinia sclerotiorum is provided, including an interfering sequence, and an expression cassette, a recombinant vector and a recombinant microorganism containing the interfering sequence.

[0037] In some embodiments of the present invention, the nucleotide sequence of the interfering sequence is shown as SEQ ID NO.3.

[0038] In the sixth aspect of the present invention, primers for amplifying the above-mentioned interfering sequences are provided.

[0039] In some embodiments of the present invention, the primers include a forward primer and a reverse primer, the nucleotide sequence of the forward primer is shown in SEQ ID NO.4, and the nucleotide sequence of the reverse primer is shown in SEQ ID NO.5.

[0040] In a seventh aspect of the present invention, a substance for inhibiting or silencing the expression of the SsCAK1 gene of Sclerotinia sclerotiorum is provided for use in any one of (a1) to (a3);

[0041] (a1) Anti-sclerotinia;

[0042] (a2) preparing products against sclerotinia sclerotinia;

[0043] (a3) Cultivation of transgenic plants resistant to sclerotinia sclerotinia.

[0044] In the eighth aspect of the present invention, a method for constructing a recombinant vector containing the interfering sequence is proposed, and the method comprises the following steps: introducing the interfering sequence into the vector.

[0045] In some embodiments of the present invention, the vector comprises a pTRV1 vector.

[0046] In a ninth aspect of the present invention, a method for preparing a transgenic plant is provided, comprising the following steps: introducing any one of the following nucleic acid molecules (b1) to (b2) into a target plant to obtain a transgenic plant;

[0047] (b1) an interfering sequence prepared from the full-length gene encoding the above protein or any fragment thereof;

[0048] (b2) The above-mentioned interfering sequence, and the expression cassette, recombinant vector and recombinant microorganism containing the interfering sequence.

[0049] In some embodiments of the present invention, the plant is a plant of the family Cruciferae, Asteraceae, Chenopodiaceae, Rutaceae, Moraceae, Leguminosae or Solanaceae.

[0050] In some embodiments of the invention, the plant is Arabidopsis thaliana or Nicotiana benthamiana.

[0051] According to some embodiments of the present invention, at least the following beneficial effects are achieved: the present invention provides the genome and protein sequence of the SsCAK1 gene of Sclerotinia sclerotiorum, which affects the growth of sclerotial hyphae, the formation of sclerotia and infection pads, and plays an important role in the drug resistance and pathogenicity of Sclerotinia sclerotiorum; by designing and synthesizing an RNAi sequence that targets and silences the SsCAK1 gene of Sclerotinia sclerotiorum, the RNAi sequence that inhibits or silences the expression of the SsCAK1 gene of Sclerotinia sclerotiorum is used to construct and obtain a silencing expression vector, and after transforming the vector into a plant, the plant can be made resistant to sclerotinia disease, which has great application prospects in plant breeding for sclerotinia disease resistance. BRIEF DESCRIPTION OF THE DRAWINGS

[0052] The present invention will be further described below with reference to the accompanying drawings and embodiments, wherein:

[0053] Figure 1 : is a graph of agarose gel electrophoresis detection results in Example 1 of the present invention, wherein A is a graph of PCR product detection results, and B is a graph of colony PCR detection results;

[0054] Figure 2 Graphs showing the results of transgenic plant detection in Example 1 of the present invention, wherein A is a phenotype graph of transgenic plants, and B is a graph showing the results of agarose gel electrophoresis detection;

[0055] Figure 3It is a graph showing the specific experimental detection results in Example 1 of the present invention, wherein A is a graph showing the detection results of the lesion area of ​​the experimental leaves, B is a graph showing the comparison of the lesion areas of the leaves of the experimental group and the control group; and C is a graph showing the detection results of the expression level of the SsCAK1 gene. DETAILED DESCRIPTION

[0056] The following will be combined with the embodiments to clearly and completely describe the concept of the present invention and the technical effects produced, so as to fully understand the purpose, characteristics and effects of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, other embodiments obtained by those skilled in the art without creative work are all within the scope of protection of the present invention.

[0057] Experimental Materials

[0058] (1) After disinfection and vernalization, seeds of plants such as Nicotiana benthamiana were inoculated on sterilized nutrient soil and cultured at 22°C for 4 weeks with 16 hours of light and 8 hours of darkness.

[0059] (2) Sclerotinia sclerotiorum strain 1980 was maintained in potato culture medium (PDA).

[0060] Example 1 Application of Sclerotinia sclerotiorum SsCAK1 gene in improving plant resistance to fungi

[0061] 1. Construction of HIGS silencing expression vector

[0062] (1) Interference sequence design

[0063] The coding sequence and amino acid sequence of SsCAK1 were extracted from the Sclerotinia genome database (http: / / www.broadinstitute org / annotation / genome / Scleraotinia sclerotiorum / Uenomeslndex html). Using the VIGS design website https: / / vigs.solgenomics.net / , specific interference sequences were designed and screened.

[0064] The nucleotide sequence of the SsCAK1 gene (SEQ ID NO.1) is as follows:

[0065]

[0066] The specific SsCAK1 protein sequence (SEQ ID NO.2) is as follows:

[0067] MDSTTDWKQDLKASERYDNILKLKKHLALGGLSGNTQKTAFEIESEAYNSSSSRATYDDLCNPTEPNAEASSSETFSAPKSPGITIGPYNNCHHISSGAVSQVYRCDTEEGSYALKVITETHNMEPHSPTREIAILKRLSHPSIISLHTTLYDQESRLVLLLPYMPYTLSDLLSRSSKGLNVGTTKKIFKELLSGLA YLHAEQIIHRDISPSNILLPHDINGKDPIVITDFGTAWHPSISSSTEPTDQKCLEVGTTCYRGPETLFSNTSYTTSLDLWSTGVLLAECLRSPPIPLLESRRGDEDGNQLGLILSMFKTLGTPTEQTWPEAMKWKTNPFQWWNIFPSKSWEELLPDAEDDGRDLVASLVIYESGKRLTAVQALKHSFFLEKLESRD.

[0068] The nucleotide sequence of the interfering sequence (SEQ ID NO.3) is as follows:

[0069] ATGGACTCCACAACAGACTGGAAACAAGACTTAAAAGCTTCTGAACGATATGATAATATCTTAAAGCTGAAGAAACATCTCGCTTGGCGGGCTCAGTGGAAACACACAGAAAACTGCATTCGAAATAGAATCAGAAGCTTATAATTCT TCGTCATCTAGAGCTACCTACGATGATTTATGCAATCCTACTGAGCCAAATGCTGAAGCCTCTTCATCAGAAACCTTTTCTGCACCCAAAAGCCCCGGCATAACCATAGGGCCCTACAACAATTGTCACCATATCTCTAGCGGCGCTGTT.

[0070] (2) Primer sequence design

[0071] Primers were designed based on the above interfering sequence (nucleotide sequence shown in SEQ ID NO.3), and the primer sequences are as follows:

[0072] SsCAK1-TFGCgaattcATGGACTCCACAACAGACTG(SEQ ID NO.4);

[0073] SsCAK1-TR GCggatccTGAGAAACAGCGCCGCTAGA (SEQ ID NO. 5).

[0074] (3) Construction of HIGS silencing expression vector

[0075] Using genomic DNA of Sclerotinia sclerotiorum (wild strain 1980) as a template, using gene-specific primers SsCAK1-TF and SsCAK1-TR with EcoRI and BamHI connectors (as shown in Table 1), PCR amplification was performed to obtain SsCAK1-specific interference fragments. The reaction system is shown in Table 2, and PCR amplification is shown in Table 3. Using cDNA of plants such as Nicotiana benthamiana as a template, using gene-specific primers NbPDS-TF and NbPDS-TR with EcoRI and BamHI connectors (as shown in Table 1), PCR amplification was performed to obtain NbPDS-specific interference fragments; using pCambia1305-GFP of GFP sequence as a template, using gene-specific primers GFP-TF-TF and GFP-TF-TR with EcoRI and BamHI connectors (as shown in Table 1), PCR amplification was performed to obtain GFP-specific interference fragments. The above-obtained PCR products were verified by agarose gel electrophoresis, and the results are shown in Table 3. Figure 1 As shown in Figure A, it can be seen that the PCR product with the correct sequence was successfully obtained. After the PCR product with the correct sequence was double-digested with EcoRI and BamHI, the SsCAK1-specific interference fragment, the NbPDS-specific interference fragment and the GFP-specific interference fragment were respectively connected to different linearized pTRV2 vectors (purchased from Changsha Boyi Biotechnology Co., Ltd.), and the positive control (pTRV2:PDS), negative control (pTRV2:GFP) and HIGS silencing expression vector of CAK1 gene (pTRV2:SsCAK1) were constructed respectively.

[0076] The recombinant bacterial solutions containing three different recombinant vectors were verified by agarose gel electrophoresis using primers SsCAK1-TF / TRV2-R, NbPDS1-TF / TRV2-R, and GFP-TF / TRV2-R. The results are as follows: Figure 1 As shown in Figure B, it can be seen that three HIGS silencing expression vectors were successfully constructed in this example.

[0077] Finally, the constructed HIGS silencing expression vector of the CAK1 gene confirmed to be correct by sequencing, the negative control expression vector and the positive control expression vector were transformed into Agrobacterium tumefaciens GV3101 by electroporation.

[0078] Table 1

[0079] Primer name Sequence (5'-3') Sequence number SsCAK1-TF GCgaattcATGGACTCCACAACAGACTG SEQ ID NO.4 SsCAK1-TR GCggatccTGAGAAACAGCGCCGCTAGA SEQ ID NO.5 NbPDS-TF GCgaattcATGCCCCAAATTGGACTTGT SEQ ID NO.6 NbPDS-TR GCggatccGAAGTACGAAACGATGATGA SEQ ID NO.7 GFP-TF GCgaattcTGGTGAGCAAGGGCGAGGAG SEQ ID NO.8 GFP-TR GCggatccTTGCCGTCGTCCTTGAAGA SEQ ID NO.9 TRV2-R TTGCCTTTGTAACCATCATC SEQ ID NO.10

[0080] Table 2

[0081] Element volume Taq enzyme 0.2μL 10X buffer 2μL 2.5mM dNTP 1.6μL Primer-F (20 μM) 0.3μL Primer-R (20 μM) 0.3μL cDNA 14.6μL

[0082] Table 3

[0083]

[0084]

[0085] 2. Agrobacterium transformation

[0086] The HIGS silencing expression vector, negative control expression vector and positive control expression vector verified correctly in step (3) were transformed into Agrobacterium for plant infection. The specific steps were referred to the instructions for transformation of Agrobacterium GV3101 competent cells of Bomed Company to obtain the positive control construct pTRV2:PDS, the negative control construct pTRV2:GFP and the experimental group pTRV2:SsCAK1 construct, and the positive single clones were selected for sequencing verification.

[0087] 3. Agrobacterium-mediated transient transformation of tobacco

[0088] (1) After disinfection and vernalization, seeds of plants such as Nicotiana benthamiana were inoculated on sterilized nutrient soil and cultured at 22°C for 4 weeks with 16 hours of light and 8 hours of darkness.

[0089] (2) Dilute the Agrobacterium cell culture of each construct (positive control construct pTRV2:PDS, negative control construct pTRV2:GFP and experimental group pTRV2:SsCAK1 construct) to OD600 = 0.4 with transformation buffer (10mM MgCl2, 10mM MES, pH 5.6, 200μM acetosyringone). Mix the Agrobacterium cell culture transformed with pTRV1 with each pTRV2-based construct 1:1 and incubate at room temperature for 1 hour. Then use a needleless syringe to infiltrate the mixed Agrobacterium solution into the first and second leaves of 2-week-old Nicotiana benthamiana. Each leaf used for inoculation is usually injected with 2 circles with a diameter of 1 cm, and 2 to 3 leaves are injected per plant. Nicotiana benthamiana plants are grown in a growth chamber for at least 14 days, verified by sequencing, and semi-quantitative PCR verification after RNA reverse transcription is extracted from the top leaves. The verification results are as follows: Figure 2 As shown in Figure B, it can be seen that the transgenic plants in the experimental group, the transgenic plants in the positive control group, and the transgenic plants in the negative control group were obtained in this example. The phenotypic results of the transgenic plants after 7 days of cultivation are shown in Figure 2. Figure 2 As shown in A, it can be seen that after 7 days, the injection of pTRV2:PDS caused the top leaves of Nicotiana benthamiana to bleach, and then gradually expanded to the whole plant, proving the feasibility of the gene silencing system. The transformed plants injected with the negative control construct pTRV2:GFP and the experimental group pTRV2:SsCAK1 construct did not show obvious growth phenotypes, indicating that the transient transformation of SsCAK1 does not cause additional damage to tobacco.

[0090] The wild-type strain 1980 of Sclerotinia sclerotiorum (gift from Jeffrey Rollins of University of Florida) was activated on a PDA plate, and the edge hyphae grown for 2 days were taken with a 2 mm diameter puncher for inoculation. The 2 mm hyphae blocks were inoculated on the leaves of the transgenic Nicotiana benthamiana plants (divided into experimental group TRV: SsCAK1 and control group TRV: GFP) that had been cultured for 2 weeks, with the bacterial surface close to the leaves. After inoculation, the inoculated leaves were placed in a controlled temperature and humidity environment, the temperature was set to 22 ° C, and the relative humidity was maintained at about 85%. After 24 hours of inoculation, the lesion area was counted using the software image J, and statistical analysis was performed using the SPSS software. The experiment was repeated 3 times, with 3-5 leaves each time. At the same time, RNA was extracted from the correctly sequenced Nicotiana benthamiana transformants (transgenic plants in the experimental group and transgenic plants in the negative control group), and reverse transcribed to synthesize cDNA. Quantitative primers were designed based on the SsCAK1 genome sequence. Real-time fluorescence quantitative PCR was performed using cDNA as a template and the Sstubulin1 housekeeping gene of Sclerotinia sclerotiorum as an internal reference gene to analyze the expression level of genes in the transformants relative to the negative control vector. The specific steps are as follows:

[0091] (1) Extraction of plant RNA

[0092] The wild type Sclerotinia sclerotiorum strain 1980 was inoculated on leaves 14 days after TRV treatment. 1 g of the sample was taken 48 hours after infection, ground into powder with liquid nitrogen, and RNA was extracted using the total RNA kit (LS1040) from Promega.

[0093] (2) Reverse transcription

[0094] The RNA extracted in the previous step was reverse transcribed according to a total amount of 500 ng per sample, and the specific steps were referred to the RNA reverse transcription kit (A5001) of Promega Company for cDNA reverse transcription. The cDNA obtained by the reaction was used for experiments immediately or stored at 4°C.

[0095] (3) Real-time fluorescence quantitative PCR reaction: the reaction system is shown in Table 4, the fluorescence quantitative primer sequences are shown in Table 5, and the reaction procedure is shown in Table 6.

[0096] Table 4 Fluorescence quantitative PCR reaction system

[0097]

[0098] Table 5 Fluorescence quantitative PCR primers

[0099]

[0100]

[0101] Table 6 Fluorescence quantitative PCR program

[0102]

[0103] The results are as follows Figure 3 As shown in the figure, it can be seen that the wild-type strain was inoculated on the leaves of tobacco and other plants after 14 days of TRV treatment, and the lesion area of ​​the experimental leaves (TRV:SsCAK1) was reduced by 51% at 24 hours compared with the control leaves (TRV:GFP). At the same time, the gene expression of SsCAK1 was determined by RT-qPCR 24 hours after TRV treatment. As expected, the expression of SsCAK1 in leaves treated with TRV:SsCAK1 was also reduced to 50% compared with the control leaves (TRV:GFP). These results show that the silencing of SsCAK1 by TRV-HIGS does reduce the virulence of the strain and enhances the host's resistance to Sclerotinia.

[0104] The embodiments of the present invention are described in detail above in conjunction with the accompanying drawings, but the present invention is not limited to the above embodiments. Various changes can be made within the knowledge of ordinary technicians in the relevant technical field without departing from the purpose of the present invention. In addition, the embodiments of the present invention and the features in the embodiments can be combined with each other without conflict.

Claims

1. A method for inhibiting or silencing Sclerotinia sclerotiorum SsCAK1 Use of a gene-expressed substance in any of (a1) to (a3); (a1) Anti-sclerotinia; (a2) preparing products for combating sclerotinia sclerotinia; (a3) breeding transgenic plants resistant to sclerotinia sclerotinia; The inhibition or silencing of Sclerotinia sclerotiorum SsCAK1 The gene expression material includes an interfering sequence, and an expression box, a recombinant vector or a recombinant microorganism containing the interfering sequence; the nucleotide sequence of the interfering sequence is shown in SEQ ID NO.

3.

2. The use according to claim 1, characterized in that The primers used to detect the interfering sequence include a forward primer and a reverse primer. The nucleotide sequence of the forward primer is shown in SEQ ID NO.4, and the nucleotide sequence of the reverse primer is shown in SEQ ID NO.

5.

3. A method for preparing a transgenic plant resistant to sclerotinia sclerotiorum, characterized in that: The following steps are involved: The nucleic acid molecule of the interfering sequence prepared from the full-length or any fragment of the coding gene of SsCAK1 protein is introduced into the target plant to obtain a transgenic plant; the nucleotide sequence of the interfering sequence is shown in SEQ ID NO.

3.

4. The preparation method according to claim 3, characterized in that: The plant is a plant of the family Cruciferae, Asteraceae, Chenopodiaceae, Rutaceae, Moraceae, Leguminosae or Solanaceae.